Literature DB >> 29359962

Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health.

Petr Holub1, Florian Kohlmayer2, Fabian Prasser2, Michaela Th Mayrhofer1, Irene Schlünder1,3, Gillian M Martin4, Sara Casati5, Lefteris Koumakis6, Andrea Wutte1, Łukasz Kozera7, Dominik Strapagiel8, Gabriele Anton9, Gianluigi Zanetti10, Osman Ugur Sezerman11, Maimuna Mendy12, Dalibor Valík13, Marialuisa Lavitrano5, Georges Dagher14, Kurt Zatloukal15, GertJan B van Ommen16, Jan-Eric Litton1.   

Abstract

The known challenge of underutilization of data and biological material from biorepositories as potential resources for medical research has been the focus of discussion for over a decade. Recently developed guidelines for improved data availability and reusability-entitled FAIR Principles (Findability, Accessibility, Interoperability, and Reusability)-are likely to address only parts of the problem. In this article, we argue that biological material and data should be viewed as a unified resource. This approach would facilitate access to complete provenance information, which is a prerequisite for reproducibility and meaningful integration of the data. A unified view also allows for optimization of long-term storage strategies, as demonstrated in the case of biobanks. We propose an extension of the FAIR Principles to include the following additional components: (1) quality aspects related to research reproducibility and meaningful reuse of the data, (2) incentives to stimulate effective enrichment of data sets and biological material collections and its reuse on all levels, and (3) privacy-respecting approaches for working with the human material and data. These FAIR-Health principles should then be applied to both the biological material and data. We also propose the development of common guidelines for cloud architectures, due to the unprecedented growth of volume and breadth of medical data generation, as well as the associated need to process the data efficiently.

Entities:  

Keywords:  FAIR (Findable, Accessible, Interoperable, and Reusable) principles; incentives; open science; privacy protection; provenance information management; quality

Mesh:

Year:  2018        PMID: 29359962      PMCID: PMC5906729          DOI: 10.1089/bio.2017.0110

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  22 in total

1.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

2.  Standard operating procedure for the collection of fresh frozen tissue samples.

Authors:  S R Mager; M H A Oomen; M M Morente; C Ratcliffe; K Knox; D J Kerr; F Pezzella; P H J Riegman
Journal:  Eur J Cancer       Date:  2007-02-27       Impact factor: 9.162

3.  The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine.

Authors:  Eric A Feldman
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

4.  Believe it or not: how much can we rely on published data on potential drug targets?

Authors:  Florian Prinz; Thomas Schlange; Khusru Asadullah
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

5.  A review of the barriers to sharing in biobanking.

Authors:  Flora Colledge; Bernice Elger; Heidi C Howard
Journal:  Biopreserv Biobank       Date:  2013-12       Impact factor: 2.300

6.  Size matters: how population size influences genotype-phenotype association studies in anonymized data.

Authors:  Raymond Heatherly; Joshua C Denny; Jonathan L Haines; Dan M Roden; Bradley A Malin
Journal:  J Biomed Inform       Date:  2014-07-16       Impact factor: 6.317

7.  The Economics of Reproducibility in Preclinical Research.

Authors:  Leonard P Freedman; Iain M Cockburn; Timothy S Simcoe
Journal:  PLoS Biol       Date:  2015-06-09       Impact factor: 8.029

8.  Ten simple rules for reproducible computational research.

Authors:  Geir Kjetil Sandve; Anton Nekrutenko; James Taylor; Eivind Hovig
Journal:  PLoS Comput Biol       Date:  2013-10-24       Impact factor: 4.475

9.  Anonymising and sharing individual patient data.

Authors:  Khaled El Emam; Sam Rodgers; Bradley Malin
Journal:  BMJ       Date:  2015-03-20

10.  A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic.

Authors:  Aaron Mobley; Suzanne K Linder; Russell Braeuer; Lee M Ellis; Leonard Zwelling
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more
  13 in total

Review 1.  Role of Biobanks for Cancer Research and Precision Medicine in Hepatocellular Carcinoma.

Authors:  Peyda Korhan; Sanem Tercan Avcı; Yeliz Yılmaz; Yasemin Öztemur Islakoğlu; Neşe Atabey
Journal:  J Gastrointest Cancer       Date:  2021-11-22

2.  Addressing barriers in comprehensiveness, accessibility, reusability, interoperability and reproducibility of computational models in systems biology.

Authors:  Anna Niarakis; Dagmar Waltemath; James Glazier; Falk Schreiber; Sarah M Keating; David Nickerson; Claudine Chaouiya; Anne Siegel; Vincent Noël; Henning Hermjakob; Tomáš Helikar; Sylvain Soliman; Laurence Calzone
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

Review 3.  Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?

Authors:  Ebtisam Alharbi; Yojana Gadiya; David Henderson; Andrea Zaliani; Alejandra Delfin-Rossaro; Anne Cambon-Thomsen; Manfred Kohler; Gesa Witt; Danielle Welter; Nick Juty; Caroline Jay; Ola Engkvist; Carole Goble; Dorothy S Reilly; Venkata Satagopam; Vassilios Ioannidis; Wei Gu; Philip Gribbon
Journal:  Drug Discov Today       Date:  2022-05-17       Impact factor: 8.369

4.  Predicting 30-Day Readmission Risk for Patients With Chronic Obstructive Pulmonary Disease Through a Federated Machine Learning Architecture on Findable, Accessible, Interoperable, and Reusable (FAIR) Data: Development and Validation Study.

Authors:  Celia Alvarez-Romero; Alicia Martinez-Garcia; Jara Ternero Vega; Pablo Díaz-Jimènez; Carlos Jimènez-Juan; María Dolores Nieto-Martín; Esther Román Villarán; Tomi Kovacevic; Darijo Bokan; Sanja Hromis; Jelena Djekic Malbasa; Suzana Beslać; Bojan Zaric; Mert Gencturk; A Anil Sinaci; Manuel Ollero Baturone; Carlos Luis Parra Calderón
Journal:  JMIR Med Inform       Date:  2022-06-02

5.  Up-to-the-Minute Privacy Policies via Gossips in Participatory Epidemiological Studies.

Authors:  Aakash Sharma; Thomas Bye Nilsen; Katja Pauline Czerwinska; Daria Onitiu; Lars Brenna; Dag Johansen; Håvard D Johansen
Journal:  Front Big Data       Date:  2021-05-13

6.  Knowledge-for-data trade at the interface between precision medicine and person-centered care.

Authors:  Srećko Gajović
Journal:  Croat Med J       Date:  2018-06-30       Impact factor: 1.351

7.  BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.

Authors:  Petr Holub; Lukasz Kozera; Francesco Florindi; Esther van Enckevort; Morris Swertz; Robert Reihs; Andrea Wutte; Dalibor Valík; Michaela Th Mayrhofer
Journal:  Eur J Hum Genet       Date:  2020-05-22       Impact factor: 4.246

8.  Data-sharing practices in publications funded by the Canadian Institutes of Health Research: a descriptive analysis.

Authors:  Kevin B Read; Heather Ganshorn; Sarah Rutley; David R Scott
Journal:  CMAJ Open       Date:  2021-11-09

9.  Evolution or Revolution? Recommendations to Improve the Swiss Health Data Framework.

Authors:  Andrea Martani; Lester Darryl Geneviève; Sophia Mira Egli; Frédéric Erard; Tenzin Wangmo; Bernice Simone Elger
Journal:  Front Public Health       Date:  2021-05-31

10.  Mind the Gap: From Tool to Knowledge Base.

Authors:  Michaela Th Mayrhofer; Irene Schlünder
Journal:  Biopreserv Biobank       Date:  2018-08-13       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.